$0.1175
At close: Jul 6, 5:00 PM EST
Comments
Loading...
Latest Anthera Pharmaceuticals Stock News | OTC:ANTH | Benzinga
Get the latest news on Anthera Pharmaceuticals stock with updates on market trends, financials, and analysis from Benzinga. Stay informed on Anthera Pharmaceuticals performance
Categories: All
Thursday, November 05, 2020
Tuesday, March 24, 2020
Friday, December 13, 2019
Wednesday, January 30, 2019
Thursday, June 28, 2018
Wednesday, June 27, 2018
Friday, May 25, 2018
Friday, May 18, 2018
Thursday, May 17, 2018
Monday, April 16, 2018
Monday, March 26, 2018
Friday, March 16, 2018
Tuesday, March 13, 2018
Monday, March 12, 2018
- Mid-Afternoon Market Update: BlueLinx Surges On Cedar Creek Acquisition; Anthera Pharmaceuticals Shares Plunge
- 32 Stocks Moving In Monday's Mid-Day Session
- Mid-Day Market Update: Dow Turns Negative; United Community Bancorp Shares Spike Higher
- Mid-Morning Market Update: Markets Open Higher; Lumentum To Acquire Oclaro For $9.99/Share
- Anthera Pharmaceuticals Shares Down 81.9% Fol...
- Anthera Pharma's Phase 3 Study of Sollpura Di...
- Anthera Phamra Halted, News Pending
Tuesday, March 06, 2018
Monday, March 05, 2018
Thursday, February 22, 2018
Wednesday, February 21, 2018
- Mid-Afternoon Market Update: Hackett Group Rises On Upbeat Earnings; QTS Realty Trust Shares Plunge
- 34 Stocks Moving In Wednesday's Mid-Day Session
- Mid-Day Market Update: Dow Gains Over 100 Points; Tile Shop Shares Fall On Earnings Miss
- Anthera Pharmaceuticals Shares Up 37.3% As Ro...
- Benzinga's Top Upgrades, Downgrades For February 21, 2018
- Roth Capital Initiates Coverage On Anthera Pharmaceuticals with Buy Rating, Announces $10.00 Price Target
